These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 29599339)
41. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Eloubeidi MA; Desmond R; Arguedas MR; Reed CE; Wilcox CM Cancer; 2002 Oct; 95(7):1434-43. PubMed ID: 12237911 [TBL] [Abstract][Full Text] [Related]
42. Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences. Gockel I; Kneist W; Junginger T World J Surg; 2006 Feb; 30(2):183-90. PubMed ID: 16425075 [TBL] [Abstract][Full Text] [Related]
44. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease. Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291 [TBL] [Abstract][Full Text] [Related]
45. Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer. de Heer EC; Hulshoff JB; Klerk D; Burgerhof JGM; de Groot DJA; Plukker JTM; Hospers GAP Ann Surg Oncol; 2017 Jul; 24(7):1811-1820. PubMed ID: 28188501 [TBL] [Abstract][Full Text] [Related]
46. Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival. Crabtree TD; Yacoub WN; Puri V; Azar R; Zoole JB; Patterson GA; Krupnick AS; Kreisel D; Meyers BF Ann Thorac Surg; 2011 May; 91(5):1509-15; discussion 1515-6. PubMed ID: 21435632 [TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of perigastric lymph nodes metastases on survival in patients with thoracic esophageal cancer. Wu ZY; Yu JC; Xu LY; Shen JH; Wu JZ; Wang SH; Fu JH; Fan YH; Yang BN; Shen ZY; Huang Q; Li EM Dis Esophagus; 2010 Jan; 23(1):40-5. PubMed ID: 19392853 [TBL] [Abstract][Full Text] [Related]
48. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer]. Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705 [TBL] [Abstract][Full Text] [Related]
49. Lymph node metastasis in early esophageal adenocarcinoma. Griffin SM; Burt AD; Jennings NA Ann Surg; 2011 Nov; 254(5):731-6; discussion 736-7. PubMed ID: 21997815 [TBL] [Abstract][Full Text] [Related]
50. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635 [TBL] [Abstract][Full Text] [Related]
51. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma. Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702 [TBL] [Abstract][Full Text] [Related]
52. Total number of resected lymph nodes predicts survival in esophageal cancer. Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631 [TBL] [Abstract][Full Text] [Related]
53. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response. Blackham AU; Yue B; Almhanna K; Saeed N; Fontaine JP; Hoffe S; Shridhar R; Frakes J; Coppola D; Pimiento JM J Surg Oncol; 2015 Nov; 112(6):597-602. PubMed ID: 26394724 [TBL] [Abstract][Full Text] [Related]
54. Prognostic Factors Among Colonic Adenocarcinomas Invading Into the Muscularis Propria. Paulsen JD; Polydorides AD Am J Surg Pathol; 2023 Aug; 47(8):859-868. PubMed ID: 37318139 [TBL] [Abstract][Full Text] [Related]
55. Invasion of poorly differentiated adenocarcinoma to the deep muscularis mucosae may be an indicator of lymph node metastasis in Barrett's esophageal cancer. Sakaguchi Y; Ono S; Fujishiro M; Yamamichi N; Koike K Dig Endosc; 2013 May; 25 Suppl 2():168-72. PubMed ID: 23617671 [TBL] [Abstract][Full Text] [Related]
56. Lymph node invasion might have more prognostic impact than R status in advanced esophageal adenocarcinoma. Cabau M; Luc G; Terrebonne E; Belleanne G; Vendrely V; Sa Cunha A; Collet D Am J Surg; 2013 Jun; 205(6):711-7. PubMed ID: 23422318 [TBL] [Abstract][Full Text] [Related]
57. Increasing tumor length is associated with regional lymph node metastases and decreased survival in esophageal cancer. Haisley KR; Hart KD; Fischer LE; Kunio NR; Bakis G; Tieu BH; Schipper PH; Sheppard BC; Hunter JG; Dolan JP Am J Surg; 2016 May; 211(5):860-6. PubMed ID: 26993752 [TBL] [Abstract][Full Text] [Related]
58. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464 [TBL] [Abstract][Full Text] [Related]
59. Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Landau MS; Hastings SM; Foxwell TJ; Luketich JD; Nason KS; Davison JM Mod Pathol; 2014 Dec; 27(12):1578-89. PubMed ID: 24762549 [TBL] [Abstract][Full Text] [Related]
60. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction. Zhang X; Watson DI; Jamieson GG Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]